JAMP-FOSFOMYCIN 3 G
FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) : 3 G · DIN 02473801 · JAMP PHARMA CORPORATION
Health Canada status: MARKETED
What is JAMP-FOSFOMYCIN?
JAMP-FOSFOMYCIN 3 G contains FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) : 3 G. It is listed in the Health Canada Drug Product Database under DIN 02473801, held by JAMP PHARMA CORPORATION, supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Aug-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is JAMP-FOSFOMYCIN used for?
JAMP-FOSFOMYCIN (fosfomycin tromethamine) is indicated in the treatment of acute uncomplicated lower urinary tract infections (acute cystitis) in women of 18 years of age and older caused by the following susceptible pathogens: Escherichia coli, Enterococcus faecalis. JAMP-FOSFOMYCIN is not indicated for the treatment of pyelonephritis or perinephric abscess.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02473801 |
|---|---|
| Brand name | JAMP-FOSFOMYCIN |
| Generic / active ingredient | FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) : 3 G |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 3 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01XX01 FOSFOMYCIN |
| AHFS class | 08:36.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Aug-2026 |
| Original market date | 2018-08-02 00:00:00 |
How is it stored and handled?
Store at controlled room temperature 15° to 30°C.
How is it supplied?
single-dose sachet
What can be used instead?
Other Canadian products sharing ATC code J01XX01 FOSFOMYCIN. 3 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| IVOZFO | 4 G | POWDER FOR SOLUTION | VERITY PHARMACEUTICALS INC. | MARKETED | DIN 02488086 |
| MONUROL | 3 G | POWDER FOR SOLUTION | ENDO OPERATIONS LTD. | MARKETED | DIN 02240335 |
| FOSFOMYCIN POWDER FOR ORAL SOLUTION | 3 G | POWDER FOR SOLUTION | ENDO OPERATIONS LTD. | CANCELLED PRE MARKET | DIN 02489457 |
| IVOZFO | 2 G | POWDER FOR SOLUTION | VERITY PHARMACEUTICALS INC. | APPROVED | DIN 02488078 |
| IVOZFO | 8 G | POWDER FOR SOLUTION | VERITY PHARMACEUTICALS INC. | APPROVED | DIN 02488094 |
Who else supplies FOSFOMYCIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FOSFOMYCIN appears in 26 registered pack listings across 7 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.